Real-World GUARDIANS Study Evaluates Enfortumab Vedotin–Pembrolizumab in Urothelial Cancer
Urothelial carcinoma, the most common form of bladder cancer, has entered a new therapeutic era with the arrival of a...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
Urothelial carcinoma, the most common form of bladder cancer, has entered a new therapeutic era with the arrival of a...
Mass General Brigham researchers have identified two genetic regulators that appear to drive the decline of cancer-fighting T cells in...
Acute myeloid leukemia, or AML, is often described as a single disease, but that label conceals a sprawling collection of...
Hormone receptor–positive early breast cancer has entered an era in which treatment decisions are increasingly shaped by biological risk, rather...
For patients with relapsed or refractory large B-cell lymphoma, reaching a complete remission after salvage therapy is a critical turning...
Sylvester Comprehensive Cancer Center has climbed dramatically in the latest U.S. News & World Report rankings, emerging as Florida’s top...
Acute myeloid leukemia (AML) is a fast-moving blood cancer in which immature myeloid cells accumulate in the bone marrow and...
Firefighters experience measurable changes in proteins circulating through their bodies within a day of battling a fire, according to a...
Weill Cornell Medicine is launching a new Department of Systems and Computational Biomedicine, an initiative designed to bring genomics, artificial...
Cisplatin has saved countless lives by attacking rapidly dividing cancer cells, but the same chemical weapon can also injure the...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine